BioCentury
ARTICLE | Clinical News

BND-11624: Phase I started

December 3, 2007 8:00 AM UTC

Brane began a double-blind, placebo-controlled, single-ascending dose, Swiss Phase I trial in 24 healthy volunteers. ...